You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cancer - Ovarian cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer After Ovarian Cancer During and/or After Therapy:

Recruiting
  • BRCA-Associated Breast Carcinoma
  • Next-generation sequencing (NGS) assay TruSight Oncology 500 (TSO 500).
  • Rome, RM, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Mar 9, 2023

Shanghai Ovarian Cancer and Family Care Project

Recruiting
  • Ovarian Cancer
    • Shanghai, Shanghai, China
      Shanghai first maternity and infant hospital
    Oct 31, 2023

    HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle

    Active, not recruiting
    • HER2-positive Breast Cancer
    • +8 more
    • pNGVL3-hICD vaccine
    • +6 more
    • Seattle, Washington
      Fred Hutchinson Cancer Research Center/University of Washington
    Nov 1, 2022

    Transforming Ovarian Cancer Diagnostic Pathways

    Not yet recruiting
    • Ovarian Cancer
      • Birmingham, United Kingdom
      • +2 more
      Nov 10, 2023

      Total Management of Ovarian Cancer

      Not yet recruiting
      • Tumor of Female Reproductive System
      • Ovarian Cancer
      • No intervention
      • (no location specified)
      Aug 30, 2023

      Epithelial Ovarian Cancer: A Retrospective Study

      Recruiting
      • Epithelial Ovarian Cancer
      • Hematologic features
      • Shanghai, Shanghai, China
        Renji Hospital Affiliated to Shanghai Jiao Tong University Schoo
      Oct 16, 2023

      Ovarian Cancer, Breast Cancer Trial in Vijayawada (Olaparib tablets, 150 mg, Lynparza® (olaparib) tablets 150 mg)

      Recruiting
      • Ovarian Cancer
      • Breast Cancer
      • Olaparib tablets, 150 mg
      • Lynparza® (olaparib) tablets 150 mg
      • Vijayawada, Andhra Pradesh, India
        Sandoz Investigative Site
      Apr 12, 2022

      Serous Ovarian Cancer, Advanced Ovarian Cancer Trial (SC0191, Gemcitabine, Paclitaxel)

      Not yet recruiting
      • Serous Ovarian Cancer
      • Advanced Ovarian Cancer
      • (no location specified)
      Sep 20, 2023

      Ovarian Cancer Recurrent Trial (Fluzopril Combined With Apatinib)

      Not yet recruiting
      • Ovarian Cancer Recurrent
      • Fluzopril Combined With Apatinib
      • (no location specified)
      Oct 22, 2023

      A Prospective, Randomized Controlled Study of Cyclophosphamide,

      Not yet recruiting
      • Epithelial Ovarian Cancer
      • Shijiazhuang, Hebei, China
        Hebei
      Aug 20, 2023

      Early Screening of Epithelial Ovarian Cancer

      Not yet recruiting
      • Ovarian Cancer
      • +2 more
      • Fragmentomics
      • (no location specified)
      Jun 26, 2023

      Ovarian Cancer Trial in Helsinki (Biomolecular profiling)

      Recruiting
      • Ovarian Cancer
      • Biomolecular profiling
      • Helsinki, Finland
        Helsinki University and Helsinki University Hospital
      Nov 1, 2023

      Platinum-resistant Ovarian Cancer

      Not yet recruiting
      • Ovarian Cancer
      • pegylated liposomal doxorubicin
      • (no location specified)
      Aug 2, 2023

      Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Beijing (HS-20089)

      Not yet recruiting
      • Ovarian Cancer
      • +3 more
      • Beijing, Beijing, China
        Lingying Wu
      Aug 22, 2023

      Ovarian Cancer Trial in France (tests to determine HRD status)

      Not yet recruiting
      • Ovarian Cancer
      • tests to determine HRD status
      • Amiens, France
      • +3 more
      Nov 22, 2023

      Metabolic Biomarkers and Their Prognostic Relationship in

      Not yet recruiting
      • Ovarian Cancer
      • No intervention
      • (no location specified)
      Aug 24, 2023

      Ovarian Cancer Trial in Pittsburgh (Olaparib tablet)

      Not yet recruiting
      • Ovarian Cancer
      • Olaparib tablet
      • Pittsburgh, Pennsylvania
        UPMC Hillman Cancer Center
      Nov 1, 2023

      Ovarian Cancer, Ovarian Tumor, Ovarian Tumor Epithelial Trial (MIRRORS Protocol, Standard Open Cytoreductive Surgery)

      Not yet recruiting
      • Ovarian Cancer
      • +5 more
      • MIRRORS Protocol
      • Standard Open Cytoreductive Surgery
      • (no location specified)
      Jul 17, 2023

      Participation Patterns Among Recurrent Ovarian Cancer Patients

      Not yet recruiting
      • Recurrent Ovarian Cancer
        • San Francisco, California
          Power Life Sciences
        Sep 30, 2023

        Ovarian Cancer Stage III, Ovarian Cancer Stage IV Trial (Artificial Intelligence)

        Not yet recruiting
        • Ovarian Cancer Stage III
        • Ovarian Cancer Stage IV
        • Artificial Intelligence
        • (no location specified)
        Aug 24, 2023

        Ovarian Cancer, Platinum-resistant Ovarian Cancer Trial in Minsk (Gemcitabine, ELENAGEN)

        Active, not recruiting
        • Ovarian Cancer
        • Platinum-resistant Ovarian Cancer
        • Minsk, Belarus
          Minsk City Clinical Oncology Center
        Jul 27, 2023

        Ovarian Cancer Trial in Roma (Blood sample)

        Recruiting
        • Ovarian Cancer
        • Blood sample
        • Roma, Italy
          Policlinico Universitario Agostino Gemelli
        Oct 10, 2023

        Ovarian Cancer, High Grade Serous Adenocarcinoma of Ovary, High Grade Endometrioid Ovarian Cancer Trial in Guangzhou (Fluzoparib

        Not yet recruiting
        • Ovarian Cancer
        • +4 more
        • Guangzhou, Guangdong, China
          Sun Yat-sen University Cancer Cetntre
        Sep 25, 2023

        ctDNA Predicts Recurrence of Advanced Ovarian Cancer After

        Recruiting
        • Ovarian Cancer Stage IV
        • Ovarian Cancer Stage III
          • Guangzhou, Guangdong, China
            Sun Yat-Sen Memorial Hospital
          Aug 30, 2023

          Assess Safety and Effectiveness of Zirabev in Domestic Various

          Not yet recruiting
          • Non-small Cell Lung Cancer
          • +7 more
          • (no location specified)
          Jun 30, 2022